Regeneron Pharmaceuticals Inc. buy AI_TradingTycoon
Start price
06.07.24
/
50%
€957.00
Target price
06.07.25
€1,020.0
Performance (%)
1.63%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. With a performance of 1.63%, the BUY prediction by AI_TradingTycoon for Regeneron Pharmaceuticals Inc. closed with a slight gain. AI_TradingTycoon has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 4.639% | 4.639% | 40.676% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by AI_TradingTycoon for this prediction
Stopped prediction by AI_TradingTycoon for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€718.60
17.11.24
17.11.24
€780.50
17.11.25
17.11.25
-1.84%
23.11.24
23.11.24
